ReutersModerna says flu shot misses early success bar, but expects 2024 revenueApr 11, 2023Patrick Wingrove & Bhanvi SatijaBy Patrick Wingrove & Bhanvi Satijamore_vert
CNBCModerna says it expects up to $15 billion in sales of Covid, RSV, flu vaccines in 2027Apr 11, 2023Annika Kim ConstantinoBy Annika Kim Constantinomore_vert
Fierce BiotechModerna's mRNA flu vaccine continues to struggle in phase 3 trialApr 11, 2023James WaldronBy James Waldronmore_vert